Mingli Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mingli Chen has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Weiguo Lu
University of Texas Southwestern Medical Center
2 shared publications - Cynthia Chuang
Stanford University
1 shared publication - Elham Rahimy
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
1 shared publication - Erqi Liu Pollom
Stanford University
1 shared publication - Gregory Szalkowski
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
1 shared publication - Hao Jiang
NeuralRad LLC, Madison, WI, USA
1 shared publication
Latest Publications
- Open Access
- 3 May 2024
- Published by MDPI AG in Bioengineering
- Vol. 11 (5) , 454
Where Does Auto-Segmentation for Brain Metastases Radiosurgery Stand Today?
Detection and segmentation of brain metastases (BMs) play a pivotal role in diagnosis, treatment planning, and follow-up evaluations for effective BM management. Given the rising prevalence of BM cases and its predominantly multiple onsets, automated segmentation is becoming necessary in stereotactic radiosurgery. It not only alleviates the clinician’s manual workload and improves clinical workflow efficiency but also ensures treatment safety, ultimately improving patient care. Recent strides in machine learning, particularly in deep learning (DL), have revolutionized medical image segmentation, achieving state-of-the-art results. This review aims to analyze auto-segmentation strategies, characterize the utilized data, and assess the performance of cutting-edge BM segmentation methodologies. Additionally, we delve into the challenges confronting BM segmentation and share insights gleaned from our algorithmic and clinical implementation experiences.
- 3 May 2024
- Published by MDPI AG in Bioengineering
- Vol. 11 (5) , 454
Open AccessWhere Does Auto-Segmentation for Brain Metastases Radiosurgery Stand Today?
Detection and segmentation of brain metastases (BMs) play a pivotal role in diagnosis, treatment planning, and follow-up evaluations for effective BM management. Given the rising prevalence of BM cases and its predominantly multiple onsets, automated segmentation is becoming necessary in stereotactic radiosurgery. It not only alleviates the clinician’s manual workload and improves clinical workflow efficiency but also ensures treatment safety, ultimately improving patient care. Recent strides in machine learning, particularly in deep learning (DL), have revolutionized medical image segmentation, achieving state-of-the-art results. This review aims to analyze auto-segmentation strategies, characterize the utilized data, and assess the performance of cutting-edge BM segmentation methodologies. Additionally, we delve into the challenges confronting BM segmentation and share insights gleaned from our algorithmic and clinical implementation experiences.
- Open Access
- 6 December 2018
- Published by MDPI AG in Applied Sciences
- Vol. 8 (12) , 2525
A Novel Markerless Lung Tumor-Tracking Method Using Treatment MV Beam Imaging
A novel method was developed to track lung tumor motion in real time during radiation therapy with the purpose to allow target radiation dose escalation while simultaneously reducing the dose to sensitive structures, thereby increasing local control without increasing toxicity. This method analyzes beam’s eye view radiation therapy treatment megavoltage (MV) images with simulated digitally reconstructed radiographs (DRRs) as references. Instead of comparing global DRRs with projection images, this method incorporates a technique that divides the global composite DRR and the corresponding MV projection into sub-images called tiles. Registration is performed independently on tile pairs in order to reduce the effects of global discrepancies due to scattering or imaging modality differences. This algorithm was evaluated by phantom studies while simulated tumors were controlled to move with various patterns in a complex humanoid torso. Approximately 15,000 phantom MV images were acquired at nine gantry angles, with different tumors moving within ranges between 10 and 20 mm. Tumors were successfully identified on every projection with a total maximum/average error of 1.84/0.98 mm. This algorithm was also applied to over 5,000 frames of MV projections acquired during radiation therapy of five lung cancer patients. This tumor-tracking methodology is capable of accurately locating lung tumors during treatment without implanting any internal fiducial markers nor delivering extra imaging radiation doses.
- 6 December 2018
- Published by MDPI AG in Applied Sciences
- Vol. 8 (12) , 2525
Open AccessA Novel Markerless Lung Tumor-Tracking Method Using Treatment MV Beam Imaging
A novel method was developed to track lung tumor motion in real time during radiation therapy with the purpose to allow target radiation dose escalation while simultaneously reducing the dose to sensitive structures, thereby increasing local control without increasing toxicity. This method analyzes beam’s eye view radiation therapy treatment megavoltage (MV) images with simulated digitally reconstructed radiographs (DRRs) as references. Instead of comparing global DRRs with projection images, this method incorporates a technique that divides the global composite DRR and the corresponding MV projection into sub-images called tiles. Registration is performed independently on tile pairs in order to reduce the effects of global discrepancies due to scattering or imaging modality differences. This algorithm was evaluated by phantom studies while simulated tumors were controlled to move with various patterns in a complex humanoid torso. Approximately 15,000 phantom MV images were acquired at nine gantry angles, with different tumors moving within ranges between 10 and 20 mm. Tumors were successfully identified on every projection with a total maximum/average error of 1.84/0.98 mm. This algorithm was also applied to over 5,000 frames of MV projections acquired during radiation therapy of five lung cancer patients. This tumor-tracking methodology is capable of accurately locating lung tumors during treatment without implanting any internal fiducial markers nor delivering extra imaging radiation doses.